Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Riñones
33
Enfermedades
24
Enfermería
13
Fisiología
8
Insuficiencia renal
7
Insuficiencia renal crónica
6
Nutrición
5
Tratamiento
5
Aparato urinario
4
Dietoterapia
4
Diálisis
4
Nefrología
4
Química clínica
4
Trasplantes de riñones
4
Diagnóstico
3
Licenciado en Enfermería
3
Aspectos nutricionales
2
Atención al paciente
2
Atlas
2
Cirugía
2
Dieta para enfermos
2
Farmacología
2
Farmacología clínica
2
Fisiología renalAparato urinario
2
Fisiopatología
2
Fisiopatología de riñones
2
Hemodiálisis
2
Medicina
2
Medicina clínica
2
Urología pediátrica
2
-
100741por Avouac, Jérôme, Drumez, Elodie, Hachulla, Eric, Seror, Raphaèle, Georgin-Lavialle, Sophie, El Mahou, Soumaya, Pertuiset, Edouard, Pham, Thao, Marotte, Hubert, Servettaz, Amélie, Domont, Fanny, Chazerain, Pascal, Devaux, Mathilde, Claudepierre, Pascal, Langlois, Vincent, Mekinian, Arsène, Maria, Alexandre Thibault Jacques, Banneville, Béatrice, Fautrel, Bruno, Pouchot, Jacques, Thomas, Thierry, Flipo, René-Marc, Richez, Christophe“…The inverse probability of treatment weighting propensity score method was used to adjust for potential confounding factors (age, sex, arterial hypertension, diabetes, smoking status, body-mass index, interstitial lung disease, cardiovascular diseases, cancer, corticosteroid use, chronic renal failure, and the underlying disease [rheumatoid arthritis vs others]). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100742por Gómez-Sámano, Miguel Ángel, Vargas-Abonce, Valerie Paola, Martínez-Sánchez, Froylan David, Palacios-Báez, Lucía, Vera-Zertuche, Juan Mauricio, Navarro-Flores, María Fernanda, Morales-García, Mariana Guadalupe, Fonseca-Correa, Jorge Ignacio, Zuarth-Vázquez, Julia María, Vega-Vega, Olynka, Correa-Rotter, Ricardo, Rincón-Pedrero, Rodolfo, Morales-Buenrostro, Luis E., Alberú-Gómez, Josefina, Ramírez-González, Julia Berenice, Pacheco-Domínguez, Reyna Lizette, López-Cervantes, Malaquías, Mendoza-de-la-Garza, María de los Ángeles, Baeza-Arias, Yolanda Victoria, Espinosa-Cuevas, Ángeles, López-Carrasco, Guadalupe, López-Estrada, Angelina, Guillén-Pineda, Luz Elizabeth, Gómez-Pérez, Francisco Javier, Cuevas-Ramos, Daniel“…CONCLUSION: A positive association between serum FGF21 and OS has been found independently of renal function in humans. Results from the present study provide novel information for deeper understanding of the role of FGF21 in OS in humans with CKD and T2D; mechanistic studies to explain the association of serum FGF21 with oxidative stress in CKD are needed.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100743por Plotnikov, Galina, Waizman, Efraim, Tzur, Irma, Yusupov, Alexander, Shapira, Yonatan, Gorelik, Oleg“…RESULTS: Statistically significant differences were observed between the groups in the proportions of males (p = 0.007); of patients with diabetes mellitus (p = 0.025), cerebrovascular disease (p < 0.001), renal failure (p = 0.003), dementia (p < 0.001), heart failure (p = 0.005), pressure sores (p < 0.001) and malignant disorders (p = 0.007); and of patients residing in nursing homes (p < 0.001). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100744por Kalinich, Mark, Murphy, William, Wongvibulsin, Shannon, Pahalyants, Vartan, Yu, Kun-Hsing, Lu, Chenyue, Wang, Feicheng, Zubiri, Leyre, Naranbhai, Vivek, Gusev, Alexander, Kwatra, Shawn G, Reynolds, Kerry L, Semenov, Yevgeniy R“…Combination immunotherapy (OR: 2.44, p<0.001) was associated with increased odds of developing irAEs requiring hospitalization, whereas older patients (OR 0.98 per additional year, p<0.001) and those with non-lung cancer were associated with decreased odds of irAEs requiring hospitalization (melanoma OR: 0.70, p=0.01, renal cell carcinoma OR: 0.71, p=0.03, other cancers OR: 0.50, p<0.001). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100745por Bagasha, Peace, Namukwaya, Elizabeth, Leng, Mhoira, Kalyesubula, Robert, Mutebi, Edrisa, Naitala, Ronald, Katabira, Elly, Petrova, Mila“…We therefore measured the quality of life (QOL) and associated factors in end stage renal disease (ESRD) patients in a major tertiary care hospital in Uganda. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100746por Rodríguez-Laiz, Gonzalo P., Melgar-Requena, Paola, Alcázar-López, Cándido F., Franco-Campello, Mariano, Villodre-Tudela, Celia, Pascual-Bartolomé, Sonia, Bellot-García, Pablo, Rodríguez-Soler, María, Miralles-Maciá, Cayetano F., Más-Serrano, Patricio, Navarro-Martínez, José A., Martínez-Adsuar, Francisco J., Gómez-Salinas, Luis, Jaime-Sánchez, Francisco A., Perdiguero-Gil, Miguel, Díaz-Cuevas, María, Palazón-Azorín, José M., Such-Ronda, José, Lluís-Casajuana, Félix, Ramia-Ángel, José M.“…Standard immunosuppression administered included steroids, tacrolimus (delayed in the setting of renal impairment, with basiliximab induction added) and mycophenolate mofetil. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100747“…Most of the patients (11 of 15) had at least one predisposing comorbidity related to the urinary tract system (8 with recurrent urinary tract infection, 7 with urinary incontinence, 3 with an indwelling catheter, 2 with renal stones, and 1 each with benign prostatic hyperplasia and a recent cystoscopy). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100748“…Extracorporeal membrane oxygenation may not be related to 30-day mortality or complications such as nosocomial pneumonia, haemorrhagic stroke, or continuous renal replacement therapy in patients with ARDS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100749“…Several factors were identified from our adjusted multivariate analyses to be associated with in-hospital mortality: increasing age (per 1-year increment; OR 1.07 (1.045 to 1.105)), hypoxia (oxygen saturation <95%; OR 4.630 (1.934 to 1.111)), opacity/infiltrate on imaging (OR 3.077 (1.276 to 7.407)), leucocytosis (white blood cell >10 (109/µL); OR 2.732 (1.412 to 5.263)), ferritin >336 ng/mL (OR 4.016 (1.195 to 13.514)), lactate dehydrogenase >200 U/L (OR 7.752 (1.639 to 37.037)), procalcitonin >0.25 ng/mL (OR 2.404 (1.011 to 5.714)), troponin I >0.03 ng/mL (OR 2.242 (1.080 to 4.673)), need for advanced oxygen support other than simple nasal cannula (OR 4.608–13.889 (2.053 to 31.250)), intensive care unit admission/transfer (OR 13.699 (6.135 to 30.303)), renal replacement therapy (OR 21.277 (5.025 to 90.909)), need for vasopressor (OR 22.222 (9.434 to 52.632)), ARDS (OR 23.810 (10.204 to 55.556)), respiratory acidosis (OR 7.042 (2.915 to 16.949)), and AKI (OR 3.571 (1.715 to 7.407)). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100750por Pilgram, Lisa, Eberwein, Lukas, Wille, Kai, Koehler, Felix C., Stecher, Melanie, Rieg, Siegbert, Kielstein, Jan T., Jakob, Carolin E. M., Rüthrich, Maria, Burst, Volker, Prasser, Fabian, Borgmann, Stefan, Müller, Roman-Ulrich, Lanznaster, Julia, Isberner, Nora, Tometten, Lukas, Dolff, Sebastian“…We further identified markedly elevated lactate dehydrogenase (> 2 × upper limit of normal, aOR 23.21, 95% CI 3.66–147.11, p < 0.001), thrombocytopenia (< 120,000/µl, aOR 11.66, 95% CI 2.49–54.70, p = 0.002), anemia (Hb < 10 g/dl, aOR 3.21, 95% CI 1.17–8.82, p = 0.024), and C-reactive protein (≥ 30 mg/l, aOR 3.44, 95% CI 1.13–10.45, p = 0.029) as predictors, while renal replacement therapy was not related to mortality (aOR 1.15, 95% CI 0.68–1.93, p = 0.611). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100751por Alfuhied, Aseel, Marrow, Benjamin A., Elfawal, Sara, Gulsin, Gaurav S., Graham-Brown, Mathew P., Steadman, Christopher D., Kanagala, Prathap, McCann, Gerry P., Singh, Anvesha“…METHODS: Sixty participants with and without cardiovascular disease (aortic stenosis (AS) (n = 16), type 2 diabetes (T2D) (n = 28), end-stage renal disease on haemodialysis (n = 10) and healthy volunteers (n = 6)) underwent two separate CMR scans 7–14 days apart. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100752por Manzoor, Daniel, Bui, Chau, Makhoul, Elias, Luthringer, Daniel, Marchevsky, Alberto, Volod, Oksana“…INTERVENTIONS: All 3 patients required mechanical ventilation support, 2 of which also required renal replacement therapy. All 3 patients were also placed on anticoagulation therapy. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100753por El Rhalete, Abdelilah, Rhazi, Inas, Bensaid, Amine, Zaid, Ikram, Bkiyer, Houssam, Ismaili, Nabila, Elouafi, Nouha, Housni, Brahim“…Among our patients, 46.42% had diabetes, 32.14% had a high blood pressure, 13.09% had a chronic renal failure and 14.28% had a history of ischemic heart disease. 14 patients (16.66%) had an elevated troponin with higher levels than 1000 ng/mL. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100754por Petricevic, Mirna, Petricevic, Mate, Pasalic, Marijan, Golubic Cepulic, Branka, Raos, Mirela, Vasicek, Vesna, Goerlinger, Klaus, Rotim, Kresimir, Gasparovic, Hrvoje, Biocina, Bojan“…The variables that entered the scoring system were: Age; Body Mass Index; Chronic Renal Failure; Preoperative Clopidogrel Exposure; Preoperative Red Blood Cells Count; Preoperative Fibrinogen Level; Preoperative Multiplate ASPI test area under the curve (AUC) units. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100755por Díaz-López, Andrés, Paz-Graniel, Indira, Ruiz, Verónica, Toledo, Estefanía, Becerra-Tomás, Nerea, Corella, Dolores, Castañer, Olga, Martínez, J. Alfredo, Alonso-Gómez, Ángel M., Wärnberg, Julia, Vioque, Jesús, Romaguera, Dora, López-Miranda, José, Estruch, Ramon, Tinahones, Francisco J., Lapetra, José, Serra-Majem, Luís, Bueno-Cavanillas, Aurora, Tur, Josep A., Sánchez, Vicente Martín, Pintó, Xavier, Delgado-Rodríguez, Miguel, Matía-Martín, Pilar, Vidal, Josep, Vázquez, Clotilde, Daimiel, Lidia, Villa, Tania Fernandez, Ros, Emilio, Eguaras, Sonia, Babio, Nancy, Sorlí, Jose V., Goday, Albert, Abete, Itziar, Sierra, Lucas Tojal, Barón-López, Francisco Javier, Torres-Collado, Laura, Morey, Marga, Garcia-Rios, Antonio, Casas, Rosa, Bernal-López, María Rosa, Santos-Lozano, José Manuel, Navarro, Adela, Gonzalez, Jose I., Zomeño, María Dolores, Zulet, Maria Angeles, Luna, Jessica Vaquero, Ramallal, Raul, Fitó, Montse, Salas-Salvadó, Jordi“…It remains unclear whether caffeinated beverages could have deleterious renal effects in elderly population with underlying comorbid conditions. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100756por Goh, Kuan Liang Shawn, Lee, Cia Sin, Koh, Choon Huat Gerald, Ling, Ng Ling, Ang, Seng Bin, Oh, Christina, Lin, Yongqing, Yuan, Wei, Zheng, Qishi Charles, Tan, Ngiap Chuan“…Blood pressure and weight control; quality of life, medication adherence, confidence in self-management, diabetic literacy and related distress and healthcare utilisation using validated questionnaires; and incident retinal, renal, cardiac and cerebrovascular complications will be compared between the two arms as secondary outcomes at stipulated time-points. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100757por Zhou, Zien, Jardine, Meg J., Li, Qiang, Neuen, Brendon L., Cannon, Christopher P., de Zeeuw, Dick, Edwards, Robert, Levin, Adeera, Mahaffey, Kenneth W., Perkovic, Vlado, Neal, Bruce, Lindley, Richard I.“…This study assessed the effects of sodium glucose cotransporter 2 inhibitors (SGLT2i) on stroke and atrial fibrillation/flutter (AF/AFL) from CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) and a meta-analysis of large cardiovascular outcome trials (CVOTs) of SGLT2i in type 2 diabetes mellitus. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100758por Borges do Nascimento, Israel Júnior, Marcolino, Milena Soriano, Abdulazeem, Hebatullah Mohamed, Weerasekara, Ishanka, Azzopardi-Muscat, Natasha, Gonçalves, Marcos André, Novillo-Ortiz, David“…“Probability of dying from any of cardiovascular, cancer, diabetes or chronic renal disease” and “suicide mortality rate” were the most commonly assessed health indicators and core priorities within the WHO General Programme of Work 2019/2023 and the EPW 2020/2025. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100759por Alexandrou, Maria-Eleni, Gkaliagkousi, Εugenia, Loutradis, Charalampos, Dimitriadis, Chrysostomos, Mitsopoulos, Efstathios, Lazaridis, Antonios, Nikolaidou, Barbara, Dolgiras, Panagiotis, Douma, Stella, Papagianni, Aikaterini, Sarafidis, Pantelis A“…BACKGROUND: Endothelial dysfunction is associated with cardiovascular events and mortality in various disease states, including end-stage renal disease (ESRD). Novel technological approaches have emerged for real-time assessment of endothelial reactivity. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100760por Alhammad, Zahrah Abbas, Aljaman, Abdulaziz Abdullah, Douba, Najah Younes, Alhamdan, Ali Saleh, Alghamdi, Abdulrahman Aidh“…This regimen has successfully maintained a stable calcium level with normal corrected calcium, and our patient has been in remission with no recurrence of renal stones or other symptoms for the past 18 months, with the last follow-up showing a calcium level of 2.64 mmol/l (2.2–2.65), PTH of 23 pmol/l (1.1–8.43), vitamin D of 24 ng/ml (20–32), albumin of 38 g/L (35–52) and creatinine of 58 umol/l (49 - 90), compared to calcium level of 2.93 mmol/l, PTH of 50 pmol/l and Vitamin D 13 ng/ml before starting treatment. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto